EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC-ND 4.0

Deprescribing interventions for gabapentinoids in adults: A scoping review

Prue A Anderson iD, Andrew J McLachlan iD, Christina Abdel Shaheed iD, Danijela Gnjidic iD, Rowena Ivers, Stephanie Mathieson iD

British Journal of Clinical Pharmacology · 2023-09 · 89 (9) · 2677-2690

DOI: 10.1111/bcp.15798 ↗

Kurz gefasst

Scoping Review in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 13.06.2023. Verfasst von Prue A Anderson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia. Hauptthemen laut MEDLINE: Deprescriptions. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emerging issue of rising gabapentinoid misuse is being recognized alongside the lack of current evidence supporting the safe and effective deprescribing of gabapentinoids. This scoping review aimed to assess the extent and nature of gabapentinoid deprescribing interventions in adults, either in reducing dosages, or prescribing of, gabapentinoids. Electronic databases were searched on 23 February 2022 without restrictions. Eligible studies included randomized, non‐randomized and observational studies that assessed an intervention aimed at reducing/ceasing the prescription/use of a gabapentinoid in adults for any indication in a clinical setting. The research outcomes investigated the type of intervention, prescribing rates, cessations, patient outcomes and adverse events. Extracted outcome data were categorized as either short (≤3 months), intermediate (>3 but

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeprescriptionsAdultHumansGabapentinDatabases, Factual

Stichwörter der Autor:innen

deprescribegabapentingabapentinoidinterventionpregabalintaperwithdraw

Substanzen

Gabapentin

Autor:innen und Institutionen

  • Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
  • Pharmacy Department, Prince of Wales Hospital, Randwick, NSW, Australia.
  • Sydney Musculoskeletal Health, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
  • Faculty of Science, Medicine and Health, University of Wollongong, Sydney, Australia.
  • Sydney Musculoskeletal Health, Kolling Institute, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, St Leonards, Australia.

ORCID-Profile: Prue A Anderson, Andrew J McLachlan, Christina Abdel Shaheed, Danijela Gnjidic, Stephanie Mathieson

Zitieren

APA

Anderson, P. A., McLachlan, A. J., Abdel Shaheed, C., Gnjidic, D., Ivers, R., & Mathieson, S. (2023). Deprescribing interventions for gabapentinoids in adults: A scoping review. British Journal of Clinical Pharmacology, 89(9), 2677-2690. https://doi.org/10.1111/bcp.15798

Vancouver

Anderson PA, McLachlan AJ, Abdel Shaheed C, Gnjidic D, Ivers R, Mathieson S. Deprescribing interventions for gabapentinoids in adults: A scoping review. British Journal of Clinical Pharmacology. 2023;89(9):2677-2690. doi:10.1111/bcp.15798

BibTeX
@article{Anderson2023,
  author = {Anderson, Prue A and McLachlan, Andrew J and Abdel Shaheed, Christina and Gnjidic, Danijela and Ivers, Rowena and Mathieson, Stephanie},
  title = {Deprescribing interventions for gabapentinoids in adults: A scoping review},
  journal = {British Journal of Clinical Pharmacology},
  year = {2023},
  volume = {89},
  number = {9},
  pages = {2677--2690},
  doi = {10.1111/bcp.15798}
}
Kostenlos starten →